DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hui R, Garon EB, Goldman JW. et al
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.
Ann Oncol 2017;
28 (04) 874-881
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.